Fei Ma - Search Results

Year	Number of Results
2002	4
2003	4
2004	2
2005	10
2006	5
2007	3
2008	16
2009	17
2010	15
2011	15
2012	33
2013	35
2014	47
2015	60
2016	68
2017	78
2018	74
2019	96
2020	131
2021	114
2022	138
2023	45

1

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer.

Zhang Y, Chen H, Mo H, Hu X, Gao R, Zhao Y, Liu B, Niu L, Sun X, Yu X, Wang Y, Chang Q, Gong T, Guan X, Hu T, Qian T, Xu B, Ma F, Zhang Z, Liu Z. Zhang Y, et al. Among authors: ma f. Cancer Cell. 2021 Dec 13;39(12):1578-1593.e8. doi: 10.1016/j.ccell.2021.09.010. Epub 2021 Oct 14. Cancer Cell. 2021. PMID: 34653365 Free article.

2

Antibody-drug conjugates in HER2-positive breast cancer.

Li L, Zhang D, Liu B, Lv D, Zhai J, Guan X, Yi Z, Ma F. Li L, et al. Among authors: ma f. Chin Med J (Engl). 2021 Dec 22;135(3):261-267. doi: 10.1097/CM9.0000000000001932. Chin Med J (Engl). 2021. PMID: 34935688 Free PMC article. Review.

3

Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial.

Xu B, Yan M, Ma F, Hu X, Feng J, Ouyang Q, Tong Z, Li H, Zhang Q, Sun T, Wang X, Yin Y, Cheng Y, Li W, Gu Y, Chen Q, Liu J, Cheng J, Geng C, Qin S, Wang S, Lu J, Shen K, Liu Q, Wang X, Wang H, Luo T, Yang J, Wu Y, Yu Z, Zhu X, Chen C, Zou J; PHOEBE Investigators. Xu B, et al. Among authors: ma f. Lancet Oncol. 2021 Mar;22(3):351-360. doi: 10.1016/S1470-2045(20)30702-6. Epub 2021 Feb 11. Lancet Oncol. 2021. PMID: 33581774 Clinical Trial.

4

A systematic review and meta-analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer.

Chen L, Zhang S, Da J, Wu W, Ma F, Tang C, Li G, Zhong D, Liao B. Chen L, et al. Among authors: ma f. Ann Palliat Med. 2021 Oct;10(10):10830-10839. doi: 10.21037/apm-21-2476. Ann Palliat Med. 2021. PMID: 34763444 Free article.

5

Melatonin ameliorates necrotizing enterocolitis by preventing Th17/Treg imbalance through activation of the AMPK/SIRT1 pathway.

Ma F, Hao H, Gao X, Cai Y, Zhou J, Liang P, Lv J, He Q, Shi C, Hu D, Chen B, Zhu L, Xiao X, Li S. Ma F, et al. Theranostics. 2020 Jun 19;10(17):7730-7746. doi: 10.7150/thno.45862. eCollection 2020. Theranostics. 2020. PMID: 32685016 Free PMC article.

6

Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.

Feng X, Jia Y, Zhang Y, Ma F, Zhu Y, Hong X, Zhou Q, He R, Zhang H, Jin J, Piao D, Huang H, Li Q, Qiu X, Zhang Z. Feng X, et al. Among authors: ma f. Autophagy. 2019 Jul;15(7):1130-1149. doi: 10.1080/15548627.2019.1570063. Epub 2019 Jan 27. Autophagy. 2019. PMID: 30686098 Free PMC article.

7

Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design.

Ma F, Zhou X, Li Q, Zhao J, Song A, An P, Du Y, Xu W, Huang G. Ma F, et al. Curr Alzheimer Res. 2019;16(7):622-632. doi: 10.2174/1567205016666190725144629. Curr Alzheimer Res. 2019. PMID: 31345146 Clinical Trial.

8

Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial.

Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F. Jia J, et al. Among authors: ma f. J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1347-1352. doi: 10.1136/jnnp-2018-320199. Epub 2019 Jul 11. J Neurol Neurosurg Psychiatry. 2019. PMID: 31296588 Clinical Trial.

9

Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Trial.

Yang T, Wang H, Xiong Y, Chen C, Duan K, Jia J, Ma F. Yang T, et al. Among authors: ma f. J Alzheimers Dis. 2020;78(4):1509-1518. doi: 10.3233/JAD-200926. J Alzheimers Dis. 2020. PMID: 33164936 Clinical Trial.

10

S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer.

Mo H, Liu X, Xue Y, Chen H, Guo S, Li Z, Wang S, Li C, Han J, Fu M, Song Y, Li D, Ma F. Mo H, et al. Among authors: ma f. Mol Cancer. 2022 Aug 30;21(1):171. doi: 10.1186/s12943-022-01642-5. Mol Cancer. 2022. PMID: 36042494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results